CEL SCI CORP

VIENNA, VA How do I update this listing?

Also known as:

  • INTERLEUKIN 2 INC

CEL SCI Corp is based out of Vienna. CEL-SCI is engaged in the research and development of the treatment of cancer and other diseases by utilizing the immune system, the body's defense system. Co.'s investigational therapy is Multikine (Leukocyte Interleukin, Injection), being studied in a pivotal global Phase III clinical trial. In addition, Co. is investigating an immunotherapy (Ligand Epitope Antigen Presentation System (LEAPS)-H1N1-DC) as a treatment for H1N1 hospitalized patients and as a vaccine (CEL-2000) for Rheumatoid Arthritis (in preclinical testing) using its LEAPS technology platform. Co.'s registered trademark include Multikine.Whalewisdom has at least 148 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2018-07-11. The notice included securities offered of Option, Warrant or Other Right to Acquire Another Security

Create Email Alert

Contact Info

cel sci corp
8229 BOONE BLVD .
VIENNA VA    22182

Business Phone: 7035069460
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Form 4 - Recent Insider Transactions

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2018-07-11 D BIOTECHNOLOGY Option, Warrant or Other Right to Acquire Another Security 78,000 78,000 0
2017-07-17 D PHARMACEUTICALS Debt,Option, Warrant or Other Right to Acquire Another Security 1,510,000 0 1,510,000
2017-02-28 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 1,000,000 1,000,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALEXANDER G. ESTERHAZY subscription required
    DIRECTOR
BRUNO BAILAVOINE subscription required
    DIRECTOR
BRUNO BAILLAVOINE subscription required
    DIRECTOR
DANIEL H. ZIMMERMAN subscription required
    EXECUTIVE OFFICER
EYAL TALOR subscription required
    EXECUTIVE OFFICER
GEERT R. KERSTEN subscription required
    EXECUTIVE OFFICER DIRECTOR
JOHN CIPRIANO subscription required
    EXECUTIVE OFFICER
PATRICIA B. PRICHEP subscription required
    EXECUTIVE OFFICER
PETER R. YOUNG subscription required
    DIRECTOR
ROBERT WATSON subscription required
    DIRECTOR

Elevate your investments